Surgery News and Research

RSS

Belatacept preserves kidney function in transplant recipients better than cyclosporine, says study

Two-year results from phase III clinical trials show the experimental immunosuppressive drug belatacept can better preserve kidney function in kidney transplant recipients while preventing graft rejection when compared with the standard immunosuppressive drug cyclosporine.

3 May 2010

Conservative therapies recommended over routine use of OTC cough/cold products in children

Despite their widespread use by parents and caregivers, over-the-counter cold and cough medicines have carried a warning by the FDA since 2008, and still have the potential to cause serious adverse events in infants and children. Conservative therapies, including nasal suctioning, humidification, and nasal saline, should be recommended over routine use of OTC cough/cold products in infants and children, according to a new commentary published in the May 2010 issue of Otolaryngology - Head and Neck Surgery.

3 May 2010

Pay-for-performance policies may create financial disincentives for doctors to treat obese patients

Pay-for-performance reimbursement of surgeons, intended to reward doctors and hospitals for good patient outcomes, may instead be creating financial incentives for discriminating against obese patients, who are much more likely to suffer expensive complications after even the most routine surgeries, according to new Johns Hopkins research.

3 May 2010

Choice of transplant center can make noteworthy difference in patients' outcomes: Study

For patients in need of a liver transplant, their choice of a transplant center can make a noteworthy difference in their outcomes, according to a Mayo Clinic study presented at the American Transplant Congress under way May 1-5 in San Diego.

3 May 2010

PEAK Surgical announces positive results from two PRECISE Clinical Studies for breast cancer diagnosis

PEAK Surgical, Inc. today announced positive results from two of its ongoing PRECISE Clinical Studies (Pulsed Plasma Radiofrequency to ReduCe Thermal Injury and Improve Surgical HEaling) demonstrating the clinical benefits of using the PEAK PlasmaBlade® tissue dissection device during lumpectomy for the diagnosis of breast cancer. The study findings were presented at the 11th Annual Meeting of the American Society of Breast Surgeons (ASBS) in poster sessions.

3 May 2010

Leptin hormone controls immune’s response to sepsis: Study

The hormone leptin, typically associated with body weight regulation, works within the central nervous system (CNS) to aid the immune system's defense against sepsis, researchers say.

3 May 2010

BSGI improves breast cancer detection

A new study, presented at the American Society of Breast Surgeons Annual Meeting in Las Vegas, found that Breast-Specific Gamma Imaging (BSGI) is highly accurate in monitoring the response of breast cancers to neoadjuvant chemotherapy.

3 May 2010

Preclinical safety data reports Natural S-equol has little effect on 2 reproductive hormones

Natural S-equol, a novel soy germ-based compound, is very likely the primary ingredient for reducing hot flushes in the dietary supplement SE5-OH, which is under development for reduction of menopause symptoms, according to pre-clinical efficacy data from studies using an animal model presented at the Experimental Biology 2010 annual meeting.

3 May 2010

Report shows increasing rates of AMD among Asians

The May issue of Ophthalmology, the journal of the American Academy of Ophthalmology, includes a surprising, first report on increasing rates of age-related macular degeneration among Asians, and describes an innovative "bypass" laser surgery that may help many people with central retinal vein occlusion avoid serious vision loss.

3 May 2010

Molecular imaging can help physicians identify aortic dissection: Research

According to research published in the May issue of The Journal of Nuclear Medicine, molecular imaging can help physicians identify aortic dissection-an often fatal blood vessel condition-and help guide treatment.

3 May 2010

Health outcomes explored at DDW 2010

Non-alcoholic fatty liver disease, which may soon be the leading indication for liver transplant, is found to be significantly associated with worse transplant outcomes. In addition, a new tool for diagnosing NAFLD represents an alternative to liver biopsy, which is more expensive and prone to complications, and ultrasound and alfafeprotein blood test screening are an effective alternative to CT scan and MRI for patients with cirrhosis at high risk for hepatocellular cancer.

3 May 2010

Adequate primary care is associated with fewer ear and throat surgeries among children

The availability of surgeons may increase the likelihood that children will receive optional ear and throat surgeries, while the availability of primary care providers, such as pediatricians and family physicians, may decrease the likelihood of children undergoing these procedures, according to research to be presented Saturday, May 1 at the Pediatric Academic Societies (PAS) annual meeting in Vancouver, British Columbia, Canada.

3 May 2010

MCA to welcome wounded veterans for free vision treatment, Hero's Night Out

Motorcycle Charity Associates announced today that they will welcome a lucky group of wounded veterans to Los Angeles for free vision treatment and a "Hero's Night Out" at the 2nd Annual Stars & Stripes event taking place on the grounds of the Playboy Mansion on Saturday, May 15th.

30 Apr 2010

Gaps in delivering publicly-funded physiotherapy across Canada

From Prince Edward Island, to Ontario, to British Columbia; it is getting harder for many Canadians to access publicly funded physiotherapy services. Health care reform initiatives have shifted outpatient physiotherapy into the community, decreasing or eliminating public funding.

30 Apr 2010

Boston Scientific to present multiple clinical abstracts on its endoscopy products at DDW 2010

Boston Scientific Corporation today announced that multiple clinical abstracts examining the diagnostic and therapeutic utility of its SpyGlass Direct Visualization System, Radial Jaw 4 Biopsy Forceps and WallFlex Duodenal Stent will be presented at Digestive Disease Week, May 1 – 5 in New Orleans.

30 Apr 2010

Researchers experiment different nanoparticles that may help surgeons remove glioblastomas

Researchers have developed a way to enhance how brain tumors appear in MRI scans and during surgery, making the tumors easier for surgeons to identify and remove.

30 Apr 2010

BCHC questions government's commitment to defend public health care

The BC Health Coalition is calling into question the provincial government's commitment to defend public health care in the courts in the wake of the recent appointment of Kip Woodward as chair of Vancouver Coastal Health - the province's second largest health authority.

30 Apr 2010

Viking Systems raises $934,897 through sale of common stock

Viking Systems Inc. announced today that it has increased its cash and liquidity position through the issuance of common stock. The Company raised $934,897 by selling an aggregate of 4,398,050 shares of its common stock through its previously announced financing facility with Dutchess Opportunity Fund, II, LP.

30 Apr 2010

IRIDEX commences commercial shipment of IQ 532 laser systems

IRIDEX Corporation, today announced the commencement of commercial shipment of the IQ 532 laser systems. The IQ 532 is a high-power, 532 nm, dual port multi-purpose laser system for use by ophthalmologists to treat sight-threatening eye diseases such as diabetic retinopathy, age-related macular degeneration and glaucoma; and for use by otolaryngologists to correct certain types of conductive hearing loss.

30 Apr 2010

ISTA Pharmaceuticals first-quarter net revenues up 39%

ISTA Pharmaceuticals, Inc., today reported financial results for the quarter ended March 31, 2010. First quarter 2010 net revenues were $28.3 million, an increase of 39% from the first quarter of 2009. Net income for the first quarter ended March 31, 2010, was $0.5 million, or $0.01 per share, compared to a net loss of $19.6 million, or $0.59 per share, for the first quarter ended March 31, 2009.

30 Apr 2010

Surgery News and Research

Belatacept preserves kidney function in transplant recipients better than cyclosporine, says study

Conservative therapies recommended over routine use of OTC cough/cold products in children

Pay-for-performance policies may create financial disincentives for doctors to treat obese patients

Choice of transplant center can make noteworthy difference in patients' outcomes: Study

PEAK Surgical announces positive results from two PRECISE Clinical Studies for breast cancer diagnosis

Leptin hormone controls immune’s response to sepsis: Study

BSGI improves breast cancer detection

Preclinical safety data reports Natural S-equol has little effect on 2 reproductive hormones

Report shows increasing rates of AMD among Asians

Molecular imaging can help physicians identify aortic dissection: Research

Health outcomes explored at DDW 2010

Adequate primary care is associated with fewer ear and throat surgeries among children

MCA to welcome wounded veterans for free vision treatment, Hero's Night Out

Gaps in delivering publicly-funded physiotherapy across Canada

Boston Scientific to present multiple clinical abstracts on its endoscopy products at DDW 2010

Researchers experiment different nanoparticles that may help surgeons remove glioblastomas

BCHC questions government's commitment to defend public health care

Viking Systems raises $934,897 through sale of common stock

IRIDEX commences commercial shipment of IQ 532 laser systems

ISTA Pharmaceuticals first-quarter net revenues up 39%

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News